,end,labels,start,text,ID
0,240,['Gene'],235,TRIP4,PMID: 26924529
1,250,['Gene'],244, ASCC1,PMID: 26924529
2,320,['Protein'],280,nuclear activating signal cointegrator 1,PMID: 26924529
3,327,['Protein'],322,ASC-1,PMID: 26924529
4,263,['Contribute'],257,encode,PMID: 26924529
5,366,['Assay/Technique'],346,autozygosity mapping,PMID: 26924529
6,393,['Assay/Technique'],371,whole-exome sequencing,PMID: 26924529
7,521,['Disease'],482, prenatal-onset spinal muscular atrophy,PMID: 26924529
8,526,['Disease'],522,(SMA,PMID: 26924529
9,561,['Disease'],529,multiple congenital contractures,PMID: 26924529
10,597,['Disease'],563,arthrogryposis multiplex congenita,PMID: 26924529
11,733,['Protein'],728,TRIP4,PMID: 26924529
12,743,['Protein'],738,ASCC1,PMID: 26924529
13,765,['Contribute'],759,led to,PMID: 26924529
14,878,['Gene'],873,Trip4,PMID: 26924529
15,888,['Gene'],883,Ascc1,PMID: 26924529
16,953,['Life Stage'],927,17.5-day-old mouse embryos,PMID: 26924529
17,1000,['Tissue Types/Organ System'],989,spinal cord,PMID: 26924529
18,1007,['Tissue Types/Organ System'],1002,brain,PMID: 26924529
19,1027,['Tissue Types/Organ System'],1009,paraspinal ganglia,PMID: 26924529
20,1036,['Tissue Types/Organ System'],1029,thyroid,PMID: 26924529
21,1062,['Tissue Types/Organ System'],1041, submandibular glands,PMID: 26924529
22,1119,['Gene'],1114,trip4,PMID: 26924529
23,1128,['Gene'],1123,ascc1,PMID: 26924529
24,1151,['Prevent'],1142,disrupted,PMID: 26924529
25,1276,['Pathway'],1200,α-motoneuron outgrowth and formation of myotomes and neuromuscular junctions,PMID: 26924529
26,1284,['Disease'],1281,led,PMID: 26924529
27,1305,['Disease'],1290,swimming defect,PMID: 26924529
28,1319,['Life Stage'],1313,larvae,PMID: 26924529
29,1340,['Assay/Technique'],1321,Immunoprecipitation,PMID: 26924529
30,1351,['Protein'],1348,ASC,PMID: 26924529
31,1421,['Protein'],1386,cysteine and glycine rich protein 1,PMID: 26924529
32,1428,['Protein'],1423,CSRP1,PMID: 26924529
33,1488,['Contribute'],1480,involved,PMID: 26924529
34,1517,['Other_useful'],1492,spinal cord regeneration ,PMID: 26924529
35,1554,['Protein'],1549,ASCC1,PMID: 26924529
36,1587,['Prevent'],1574,downregulated,PMID: 26924529
37,1669,['Gene'],1661,SERPINF1,PMID: 26924529
38,1675,['Gene'],1671,DAB1,PMID: 26924529
39,1683,['Gene'],1677,SEMA3D,PMID: 26924529
40,1691,['Gene'],1685,SEMA3A,PMID: 26924529
41,1737,['Gene'],1728,TNFRSF11B,PMID: 26924529
42,1745,['Gene'],1739,RASSF2,PMID: 26924529
43,1751,['Gene'],1747,STC1,PMID: 26924529
44,1848,['Contribute'],1842,result,PMID: 26924529
45,1906,['Disease'],1854,clinical syndrome affecting the neuromuscular system,PMID: 26924529
0,63,['Protein'],38, CXC chemokine receptor 3,PMID: 15178708
1,70,['Protein'],65,CXCR3,PMID: 15178708
2,130,['Protein'],120,IFN- gamma,PMID: 15178708
3,154,['Protein'],132,CXC chemokine ligand 9,PMID: 15178708
4,161,['Protein'],156,CXCL9,PMID: 15178708
5,195,['Protein'],163, IFN-inducible protein 10/CXCL10,PMID: 15178708
6,258,['Protein'],245,I-TAC)/CXCL11,PMID: 15178708
7,267,['Contribute'],260,attract,PMID: 15178708
8,280,['Cell Type'],268,CXCR3+ cells,PMID: 15178708
9,310,['Cell Type'],289,CD45RO+ T lymphocytes,PMID: 15178708
10,319,['Cell Type'],311, B cells,PMID: 15178708
11,345,['Cell Type'],325,natural killer cells,PMID: 15178708
12,408,['Prevent'],397,antagonists,PMID: 15178708
13,433,['Protein'],412, chemokine receptor 3,PMID: 15178708
14,439,['Protein'],435,CCR3,PMID: 15178708
15,527,['Protein'],522,I-TAC,PMID: 15178708
16,580,['Contribute'],570,antagonist,PMID: 15178708
17,589,['Protein'],585,CCR5,PMID: 15178708
18,596,['Protein'],591,I-TAC,PMID: 15178708
19,606,['Prevent'],597,inhibited,PMID: 15178708
20,673,['Protein'],622,macrophage-inflammatory protein-1alpha (MIP-1alpha),PMID: 15178708
21,695,['Protein'],674,CC chemokine ligand 3,PMID: 15178708
22,701,['Protein'],697,CCL3,PMID: 15178708
23,733,['Protein'],729,CCR5,PMID: 15178708
24,750,['Cell Type'],741,monocytes,PMID: 15178708
25,854,['Protein'],848,RANTES,PMID: 15178708
26,860,['Protein'],856,CCL5,PMID: 15178708
27,879,['Protein'],865,MIP-1beta/CCL4,PMID: 15178708
28,910,['Protein'],906,CCR5,PMID: 15178708
29,925,['Prevent'],916,inhibited,PMID: 15178708
30,960,['Cell Type'],951,monocytes,PMID: 15178708
31,1088,['Protein'],1083,I-TAC,PMID: 15178708
32,1096,['Prevent'],1089,reduced,PMID: 15178708
33,1101,['Protein'],1097,CCR5,PMID: 15178708
34,1197,['Protein'],1194,K17,PMID: 15178708
35,1202,['Protein'],1199,K49,PMID: 15178708
36,1211,['Protein'],1208,Q51,PMID: 15178708
37,1220,['Protein'],1215,I-TAC,PMID: 15178708
38,1228,['Protein'],1224,CCR5,PMID: 15178708
39,1189,['Protein'],1174, potential role,PMID: 15178708
40,1190,['Contribute'],1189, ,PMID: 15178708
41,1287,['Protein'],1281, I-TAC,PMID: 15178708
42,1312,['Prevent'],1293,negative modulator ,PMID: 15178708
43,1324,['Cell Type'],1315,leukocyte,PMID: 15178708
44,1359,['Protein'],1354,I-TAC,PMID: 15178708
45,1484,['Protein'],1480,CCR3,PMID: 15178708
46,1497,['Protein'],1493,CCR5,PMID: 15178708
0,57,['Disease'],34, Traumatic brain injury,PMID: 26894518
1,62,['Disease'],59,TBI,PMID: 26894518
2,91,['Disease'],86,death,PMID: 26894518
3,112,['Disease'],96,severe morbidity,PMID: 26894518
4,82,['Contribute'],68, leading cause,PMID: 26894518
5,152,['Life Stage'],135,full-term infants,PMID: 26894518
6,218,['Disease'],215,TBI,PMID: 26894518
7,322,['Tissue Types/Organ System'],310,infant brain,PMID: 26894518
8,579,['Assay/Technique'],576,MRI,PMID: 26894518
9,600,['Assay/Technique'],584,serum biomarkers,PMID: 26894518
10,657,['Disease'],654,TBI,PMID: 26894518
11,684,['Cell Type'],663,preclinical rat model,PMID: 26894518
12,761,['Protein'],724,neuro-reparative agent erythropoietin,PMID: 26894518
13,766,['Protein'],763,EPO,PMID: 26894518
14,780,['Contribute'],771,promoting,PMID: 26894518
15,931,['Assay/Technique'],905,controlled cortical impact,PMID: 26894518
16,936,['Assay/Technique'],933,CCI,PMID: 26894518
17,979,['Life Stage'],955,postnatal Day (P)12 rats,PMID: 26894518
18,1100,['Protein'],1097,EPO,PMID: 26894518
19,1196,['Assay/Technique'],1166,administered intraperitoneally,PMID: 26894518
20,1299,['Assay/Technique'],1259, immunoassay of injured cortex and serum,PMID: 26894518
21,1373,['Assay/Technique'],1350,digitized gait analyses,PMID: 26894518
22,1378,['Assay/Technique'],1375,MRI,PMID: 26894518
23,1402,['Assay/Technique'],1383, serum immunoassay.,PMID: 26894518
24,1553,['Assay/Technique'],1550,CCI,PMID: 26894518
25,1727,['Disease'],1695,leptomeningeal cyst-like lesions,PMID: 26894518
26,1745,['Assay/Technique'],1742,MRI,PMID: 26894518
27,1694,['Contribute'],1685,developed,PMID: 26894518
28,1805,['Assay/Technique'],1793,Western blot,PMID: 26894518
29,1821,['Protein'],1818,EPO,PMID: 26894518
30,1855,['Contribute'],1846,increased,PMID: 26894518
31,1877,['Tissue Types/Organ System'],1863,injured cortex,PMID: 26894518
32,1910,['Assay/Technique'],1897,Western blots,PMID: 26894518
33,1931,['Contribute'],1923,elevated,PMID: 26894518
34,1970,['Disease'],1932,ipsilateral cortex calpain degradation,PMID: 26894518
35,2054,['Protein'],2019, potassium chloride cotransporter 2,PMID: 26894518
36,2060,['Protein'],2056,KCC2,PMID: 26894518
37,2122,['Protein'],2115,GFAP-DP,PMID: 26894518
38,2113,['Protein'],2082,glial fibrillary acidic protein,PMID: 26894518
39,2158,['Protein'],2154,GFAP,PMID: 26894518
40,2238,['Assay/Technique'],2214,electrochemiluminescence,PMID: 26894518
41,2264,['Contribute'],2256,revealed,PMID: 26894518
42,2307,['Protein'],2280,tumor necrosis factor alpha,PMID: 26894518
43,2313,['Protein'],2309,TNFα,PMID: 26894518
44,2337,['Protein'],2328,chemokine,PMID: 26894518
45,2359,['Protein'],2354,CXCL1,PMID: 26894518
46,2525,['Protein'],2522,EPO,PMID: 26894518
47,2557,['Assay/Technique'],2554,MRI,PMID: 26894518
48,2576,['Tissue Types/Organ System'],2565,ipsilateral,PMID: 26894518
49,2594,['Tissue Types/Organ System'],2581,contralateral,PMID: 26894518
50,2601,['Tissue Types/Organ System'],2595,cortex,PMID: 26894518
51,2914,['Protein'],2909,CXCL1,PMID: 26894518
52,3187,['Assay/Technique'],3184,CCI,PMID: 26894518
53,3253,['Protein'],3250,EPO,PMID: 26894518
54,3244,['Contribute'],3236,resolved,PMID: 26894518
0,39,['Disease'],25,Muscle wasting,PMID: 30639329
1,50,['Disease'],43,atrophy,PMID: 30639329
2,124,['Disease'],116,diabetes,PMID: 30639329
3,105,['Contribute'],66,associated with human systemic diseases,PMID: 30639329
4,132,['Disease'],126,cancer,PMID: 30639329
5,152,['Disease'],138,kidney failure,PMID: 30639329
6,206,['Assay/Technique'],181,transcriptional profiles ,PMID: 30639329
7,296,['Tissue Types/Organ System'],278,atrophying muscles,PMID: 30639329
8,394,['Disease'],380,muscle atrophy,PMID: 30639329
9,490,['Assay/Technique'],474,cDNA microarrays,PMID: 30639329
10,714,['Gene'],707,atrophy,PMID: 30639329
11,742,['Gene'],738,APLN,PMID: 30639329
12,749,['Gene'],744,DUSP5,PMID: 30639329
13,755,['Gene'],751,IGF1,PMID: 30639329
14,764,['Gene'],757,PIK3IP1,PMID: 30639329
15,772,['Gene'],766,KLHL38,PMID: 30639329
16,778,['Gene'],774,PI15,PMID: 30639329
17,788,['Gene'],784,MKL1,PMID: 30639329
18,805,['Prevent'],790,did not respond,PMID: 30639329
19,841,['Contribute'],832,responded,PMID: 30639329
20,881,['Assay/Technique'],856, testosterone replacement,PMID: 30639329
21,819,['Assay/Technique'],809,castration,PMID: 30639329
0,70,['Assay/Technique'],39,genome-wide association studies,PMID: 22962313
1,76,['Assay/Technique'],72,GWAS,PMID: 22962313
2,404,['Assay/Technique'],400,GWAS,PMID: 22962313
3,501,['Assay/Technique'],471,single nucleotide polymorphism,PMID: 22962313
4,507,['Assay/Technique'],503,SNPs,PMID: 22962313
5,592,['Assay/Technique'],575,literature mining,PMID: 22962313
6,627,['Assay/Technique'],596, gene ontology (GO) hierarchies,PMID: 22962313
7,574,['Contribute'],560, determined by,PMID: 22962313
8,917,['Gene'],911,FBXL20,PMID: 22962313
9,1009,['Gene'],1004,INHBC,PMID: 22962313
10,1015,['Gene'],1011,LRP2,PMID: 22962313
11,1024,['Gene'],1017,PLEKHA1,PMID: 22962313
12,1032,['Gene'],1026,SLC3A2,PMID: 22962313
13,1043,['Gene'],1037,SLC7A6,PMID: 22962313
14,1190,['Gene'],1183,PLEKHA1,PMID: 22962313
15,1201,['Gene'],1195,FBXL20,PMID: 22962313
16,1241,['Contribute'],1229,supported by,PMID: 22962313
17,1263,['Assay/Technique'],1259,eGFR,PMID: 22962313
18,282,['Assay/Technique'],278,eGFR,PMID: 22962313
19,276,['Assay/Technique'],240,estimated glomerular filtration rate,PMID: 22962313
20,1353,['Assay/Technique'],1349,eGFR,PMID: 22962313
21,1385,['Protein'],1381,LRP2,PMID: 22962313
22,1482,['Assay/Technique'],1478,eGFR,PMID: 22962313
23,1492,['Protein'],1488,DAB2,PMID: 22962313
24,1550,['Tissue Types/Organ System'],1544,kidney,PMID: 22962313
25,304,['Tissue Types/Organ System'],298,kidney,PMID: 22962313
26,418,['Assay/Technique'],414,eGFR,PMID: 22962313
27,668,['Assay/Technique'],664,eGFR,PMID: 22962313
28,1708,['Assay/Technique'],1704,eGFR,PMID: 22962313
